新型标志物对心血管疾病预测作用
Predictive Effect of Novel Markers on Cardiovascular Disease
摘要: 心血管疾病导致的发病和死亡风险显著增加，对人类生命健康造成重要影响。心血管疾病发生日益年轻化，人们对相关生物标记物对于心血管疾病的识别越来越感兴趣。生物标志物可分为四种类型：诊断性生物标志物促进疾病的早期诊断、预后生物标志物估计疾病进程、预测性生物标志物用于预测治疗的反应、治疗性生物标志物发现靶点。当前生物标志物除了传统的单指标对于心血管危险预测之外，某些多指标组合可能对于疾病的预测也被广泛提及，在改善心血管疾病风险预测方面显示出巨大潜力。进一步的研究需要评估生物标志物的有效性，以及将生物标志物纳入临床实践的策略是否有助于优化决策和治疗管理。
Abstract: Cardiovascular diseases significantly increase the risk of morbidity and mortality, which has a significant impact on human life and health. The incidence of cardiovascular disease is becoming younger and younger, and people are more and more interested in the identification of cardiovascular disease with related biomarkers. Biomarkers can be divided into four types: diagnostic biomarkers promote early diagnosis of disease, prognostic biomarkers estimate disease progression, predictive biomarkers are used to predict response to treatment, and therapeutic biomarkers discover targets. In addition to the traditional single-indicator prediction of cardiovascular risk, some combinations of multi-indicator predictors of disease have also been widely mentioned, which shows great potential in improving the prediction of cardiovascular disease risk. Further research is needed to assess the effectiveness of biomarkers and whether strategies to incorporate biomarkers into clinical practice can help optimize decision making and treatment management.
文章引用：邹京燕, 许慧宁. 新型标志物对心血管疾病预测作用[J]. 临床医学进展, 2022, 12(4): 2898-2903. https://doi.org/10.12677/ACM.2022.124417

参考文献

[1] Nam, S.H., Kang, S.G. and Song, S.W. (2017) The Neutrophil-Lymphocyte Ratio Is Associated with Coronary Artery Calcification in Asymptomatic Korean Males: A Cross Sectionalstudy. BioMed Research International, 2017, Article ID: 1989417. [Google Scholar] [CrossRef] [PubMed]
[2] Karaman, M., Balta, S., Seyit Ahmet, A.Y., Cakar, M., Naharci, I., Demirkol, S., et al. (2013) The Comparative Effects of Valsartan and Amlodipine on VWF Levels and N/L Ratio in Patients with Newly Diagnosed Hypertension. Clinical and Experimental Hypertension, 35, 516-522. [Google Scholar] [CrossRef] [PubMed]
[3] Balta, S., Kurtoglu, E., Kucuk, U., Demirkol, S. and Öztürk, C. (2014) Neutrophil-Lymphocyte Ratio as an Important Assessment Tool. Expert Review of Cardiovascular Therapy, 12, 537-538. [Google Scholar] [CrossRef] [PubMed]
[4] Horne, B.D., Anderson, J.L., John, J.M., Weaver, A., Bair, T.L., Jensen, K.R., et al. (2005) Which White Blood Cell Subtypes Predict Increased Cardiovascularrisk? Journal of the American College of Cardiology, 45, 1638-1643. [Google Scholar] [CrossRef] [PubMed]
[5] Yu, X.Y., Li, X.S., Li, Y., Liu, T., Wang, R.T. (2015) Neutrophil-Lymphocyte Ratio Is Associated with Arterial Stiffness in Postmenopausal Women with Osteoporosis. Archives of Gerontology and Geriatrics, 61, 76-80. [Google Scholar] [CrossRef] [PubMed]
[6] 董荣静, 石柔, 董雪娥, 颜穗珺, 李会芳. 中性粒细胞与淋巴细胞比值、血小板与淋巴细胞比值与2型糖尿病患者颈动脉粥样硬化的相关性[J]. 中华临床医师杂志(电子版), 2017, 11(2): 179-182.
[7] Park, B.J., Shim, J.Y., Lee, H.R., Lee, J.H., Jung, D.H., Kim, H.B., et al. (2011) Relationship of Neutrophil-Lymphocyte Ratio with Arterial Stiffness and Coronary Calcium Score. Clinica Chimica Acta, 412, 925-929. [Google Scholar] [CrossRef] [PubMed]
[8] Park, J.J., Jang, H.J., Oh, I.Y., et al. (2013) Prognostic Value of Neutrophil to Lymphocyte Ratio in Patients Presenting With ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention. American Journal of Cardiology, 111, 636-642.
[9] Kotnik, P., Fischer-Posovszky, P. and Wabitsch, M. (2011) RBP4: A Controversial Adipokine. European Journal of Endocrinology, 165, 703-711. [Google Scholar] [CrossRef] 
[10] Yang, Q., Graham, T.E., Mody, N., Preitner, F., Peroni, O.D., Zabolotny, J.M., et al. (2005) Serum Retinol Binding Protein 4 Contributes to Insulin Resistance in Obesity and Type 2 Diabetes. Nature, 436, 356-362.
[11] Bobbert, T., Raila, J., Schwarz, F., Mai, K., Henze, A., Pfeiffer, A.F., et al. (2010) Relation between Retinol, Retinol-Binding Protein 4, Transthyretin and Carotid Intima Media Thickness. Atherosclerosis, 213, 549-551. [Google Scholar] [CrossRef] [PubMed]
[12] Liu, Y., Wang, D., Li, D., Sun, R. and Xia, M. (2014) Associations of Retinol-Binding Protein 4 with Oxidative Stress, Inflammatory Markers, and Metabolic Syndrome in a Middle-Aged and Elderly Chinese Population. Diabetology & Metabolic Syndrome, 6, Article No. 25. [Google Scholar] [CrossRef] [PubMed]
[13] Majerczyk, M., Kocelak, P., Choreza, P., Arabzada, H., Owczarek, A.J., Bozentowicz Wikarek, M., et al. (2018) Components of Metabolic Syndrome in Relation to Plasma Levels of Retinol Binding Protein 4 (RBP4) in a Cohort of People Aged 65 Years and Older. Journal of Endocrinological Investigation, 41, 1211-1219. [Google Scholar] [CrossRef] [PubMed]
[14] Lambadiari, V., Kadoglou, N.P., Stasinos, V., Maratou, E., Antoniadis, A., Kolokathis, F., et al. (2014) Serum Levels of Retinol-Binding Protein-4 Are Associated with the Presence and Severity of Coronary Artery Disease. Cardiovascular Diabetology, 13, Article No. 121. [Google Scholar] [CrossRef] [PubMed]
[15] Sun, Q., Kiernan, U.A., Shi, L., Phillips, D.A., Kahn, B.B., Hu, F.B., et al. (2013) Plasma Retinol-Binding Protein 4 (RBP4) Levels and Risk of Coronary Heart Disease: A Prospective Analysis among Women in the Nurses’ Health Study. Circulation, 127, 1938-1987. [Google Scholar] [CrossRef] 
[16] Rodríguez-Morales, A.J., Bonilla-Aldana, D.K., Suárez, J.A., Franco-Paredes, C., Forero-Peña, D.A., Mattar, S., et al. (2021) Yellow Fever Reemergence in Venezuela Implications for International Travelers and Latin American Countries during the COVID-19 Pandemic. Travel Medicine and Infectious Disease, 44, 102192. [Google Scholar] [CrossRef] [PubMed]
[17] Ahn, N. and Kim, K. (2016) High-Density Lipoprotein Cholesterol (HDL-C) in Cardiovascular Disease: Effect of Exercise Training. Integrative Medicine Research, 5, 212-215. [Google Scholar] [CrossRef] [PubMed]
[18] Kosmas, C.E., Martinez, I., Sourlas, A., Campos, F.N., Torres, V., Montan, P.D., et al. (2018) High-Density Lipoprotein (HDL) Functionality and Its Relevance to Atherosclerotic Cardiovascular Disease. Drugs in Context, 7, Article ID: 212525. [Google Scholar] [CrossRef] [PubMed]
[19] Decharatchakul, N., Settasatian, C., Settasatian, N., Komanasin, N., Kukongviriyapan, U., Intharaphet, P., et al. (2019) Association of Genetic Polymorphisms in SOD2, SOD3, GPX3, and GSTT1 with Hypertriglyceridemia and Low HDL-C Level in Subjects with High Risk of Coronary Artery Disease. PeerJ, 7, Article No. e7407. [Google Scholar] [CrossRef] [PubMed]
[20] 陈明丹. 血浆致动脉硬化指数在心血管疾病中的应用进展[J]. 中国动脉硬化杂志, 2020, 28(3): 273-276.
[21] Staiger, H., Keuper, M., Berti, L., Hrabe, D.A.M. and Haring, H.U. (2017) Fibroblast Growth Factor 21-Metabolic Role in Mice and Men. Endocrine Reviews, 38, 468-488. [Google Scholar] [CrossRef] [PubMed]
[22] Recinella, L., Leone, S., Ferrante, C., Chiavaroli, A., Di Nisio, C., Martinotti, S., et al (2017) Effects of Central Fibroblast Growth Factor 21 (FGF21) in Energy Balance. Journal of Biological Regulators and Homeostatic Agents, 31, 603-613.
[23] Sheehan, S.M. and Allen, R.E. (1999) Skeletal Muscle Satellite Cell Proliferation in Response to Members of the Fibroblast Growth Factor Family and Hepatocyte Growth Factor. Journal of Cellular Physiology, 181, 499-506. [Google Scholar] [CrossRef] 
[24] Krejci, P., Prochazkova, J., Bryja, V., Kozubik, A. and Wilcox, W.R. (2009) Molecular Pathology of the Fibroblast Growth Factor Family. Human Mutation, 30, 1245-1255. [Google Scholar] [CrossRef] [PubMed]
[25] Ying, L., Li, N., He, Z., Zeng, X., Nan, Y., Chen, J., et al. (2019) Fibroblast Growth Factor 21 Ameliorates Diabetes-Induced Endothelial Dysfunction in Mouse Aorta via Activation of the CaMKK2/AMPKa Signaling Pathway. Cell Death & Disease, 10, Article No. 665. [Google Scholar] [CrossRef] [PubMed]
[26] Wang, X.M., Song, S.S., Xiao, H., Gao, P., Li, X.J. and Si, L.Y. (2014) Fibroblast Growth Factor 21 Protects against High Glucose Induced Cellular Damage and Dysfunction of Endothelial Nitric-Oxide Synthase in Endothelial Cells. Cellular Physiology and Biochemistry, 34, 658-671. [Google Scholar] [CrossRef] [PubMed]
[27] Corrado, E., Rizzo, M., Tantillo, R., Muratori, I., Bonura, F., Vitale, G., et al. (2006) Markers of Inflammation and Infection Influence the Outcome of Patients with Baseline Asymptomatic Carotid Lesions: A 5-Year Follow-Up Study. Stroke, 37, 482-486. [Google Scholar] [CrossRef] 
[28] Corrado, E., Rizzo, M., Coppola, G., Muratori, I., Carella, M. and Novo, S. (2008) Endothelial Dysfunction and Carotid Lesions Are Strong Predictors of Clinical Events in Patients with Early Stages of Atherosclerosis: A 24-Month Follow-up Study. Coronary Artery Disease, 19, 139-144. [Google Scholar] [CrossRef] 
[29] Burke, G.L., Evans, G.W., Riley, W.A., Sharrett, A.R., Howard, G., Barnes, R.W., et al. (1995) Arterial Wall Thickness Is Associated with Prevalent Cardiovascular Disease in Middle-Aged Adults. The Atherosclerosis Risk in Communities (ARIC) Study. Stroke, 26, 386-391. [Google Scholar] [CrossRef] 
[30] Corretti, M.C., Anderson, T.J., Benjamin, E.J., Celermajer, D., Charbonneau, F., Creager, M.A., et al. (2002) Guidelines for the Ultrasound Assessment of Endothelialdependent Flow-Mediated Vasodilation of the Brachial Artery: A Report of the International Brachial Artery Reactivity Task Force. Journal of the American College of Cardiology, 39, 257-265. [Google Scholar] [CrossRef] 

为你推荐